These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 37587846

  • 1. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
    Shah AM, Vodovotz Y, Yoshimura N, Chermansky CJ, Fitzgerald J, Tyagi P.
    Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
    [Abstract] [Full Text] [Related]

  • 2. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
    Jiang YH, Jhang JF, Kuo HC.
    Diagnostics (Basel); 2022 Apr 27; 12(5):. PubMed ID: 35626252
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH, Jhang JF, Hsu YH, Kuo HC.
    Int J Mol Sci; 2022 Oct 10; 23(19):. PubMed ID: 36233356
    [Abstract] [Full Text] [Related]

  • 4. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL, Preston DM, Moldwin RM, Erickson DR, Mowlazadeh B, Ma F, Kouzoukas DE, Meyer-Siegler KL, Fall M.
    Urology; 2018 Jun 10; 116():55-62. PubMed ID: 29580781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Optimization study of an animal model for interstitial cystitis/bladder pain syndrome based on the dose effect of cyclophosphamide].
    Ke H, Wang Q, Xu K.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Oct 18; 56(5):908-912. PubMed ID: 39397473
    [Abstract] [Full Text] [Related]

  • 10. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
    Wang L, Gao J, Zheng S, Wang Z, Zheng S, Luo Z.
    Arch Esp Urol; 2024 May 18; 77(4):353-358. PubMed ID: 38840277
    [Abstract] [Full Text] [Related]

  • 11. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR, Jiang YH, Jhang JF, Kuo HC.
    Biomedicines; 2022 May 17; 10(5):. PubMed ID: 35625885
    [Abstract] [Full Text] [Related]

  • 12. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E, Impellizzeri D, Cervigni M, Porru D, Sommariva M, Cordaro M, Siracusa R, Fusco R, Gugliandolo E, Crupi R, Schievano C, Inferrera A, Di Paola R, Cuzzocrea S, Urology Study Group.
    Pharmacol Res; 2018 Aug 17; 134():16-30. PubMed ID: 29800607
    [Abstract] [Full Text] [Related]

  • 13. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
    Yu WR, Jiang YH, Jhang JF, Kuo HC.
    Int J Mol Sci; 2023 Jul 27; 24(15):. PubMed ID: 37569430
    [Abstract] [Full Text] [Related]

  • 14. Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal.
    Fang W, Song Q, Lv T, Lv J, Cai Z, Wang Z, Song X, Ji X, Huang J.
    Int Urol Nephrol; 2023 Dec 27; 55(12):3065-3075. PubMed ID: 37594700
    [Abstract] [Full Text] [Related]

  • 15. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
    Cui X, Jing X, Lutgendorf SK, Bradley CS, Schrepf A, Erickson BA, Magnotta VA, Ness TJ, Kreder KJ, O'Donnell MA, Luo Y.
    Am J Physiol Renal Physiol; 2019 Jul 01; 317(1):F90-F98. PubMed ID: 31091120
    [Abstract] [Full Text] [Related]

  • 16. Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study.
    Schrepf A, Bradley CS, O'Donnell M, Luo Y, Harte SE, Kreder K, Lutgendorf S, Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
    Brain Behav Immun; 2015 Oct 01; 49():66-74. PubMed ID: 25771510
    [Abstract] [Full Text] [Related]

  • 17. Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms.
    Schrepf A, O'Donnell M, Luo Y, Bradley CS, Kreder K, Lutgendorf S, Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
    Pain; 2014 Sep 01; 155(9):1755-1761. PubMed ID: 24907404
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic Effects of AF219 on Interstitial Cystitis/Bladder Pain Syndrome Induced by Cyclophosphamide or Water Avoidance Stress in Rats.
    Avci IE, Teke K, Gocmez SS, Kasap M, Akpinar G, Yaprak Bayrak B, Celebi G, Sarihan M, Utkan T, Ozkurkcugil C.
    Int Urogynecol J; 2024 Mar 01; 35(3):677-688. PubMed ID: 38376547
    [Abstract] [Full Text] [Related]

  • 19. Cystoscopic characteristic findings of interstitial cystitis and clinical implications.
    Yu WR, Jiang YH, Jhang JF, Kuo HC.
    Tzu Chi Med J; 2024 Mar 01; 36(1):30-37. PubMed ID: 38406570
    [Abstract] [Full Text] [Related]

  • 20. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
    Jiang YH, Jhang JF, Ho HC, Chiou DY, Kuo HC.
    Biomedicines; 2022 Jul 14; 10(7):. PubMed ID: 35885006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.